Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tarning

Showing results (61-70 of 248) with videos related to

Pageof 25
Sort By:
British Journal of Clinical Pharmacology|March 29, 2012
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometricsJ G Coen van Hasselt, Marilee A Andrew, Mary F Hebert, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2013
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in UgandaJoel Tarning, Frank Kloprogge, Mehul Dhorda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2018
Effect of Antiretroviral Therapy on Plasma Concentrations of Chloroquine and Desethyl-chloroquineMatthew M Ippolito, Jeffrey M Jacobson, Michael M Lederman, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN)Chris Lourens, Niklas Lindegardh, Karen I Barnes, et al.
Plos One|November 13, 2025
Mass spectrometry-based metabolomics uncovers distinct metabolic signatures and potential therapeutic targets in Plasmodium knowlesiNaphatsamon Uthailak, Sadudee Chotirat, Ammarind Anatjitsupha, et al.
Current Research in Parasitology & Vector-Borne Diseases|June 22, 2026
Shared urinary metabolomic signatures as potential biomarkers for early intestinal <i>Schistosoma</i> infection across multiple speciesPeerut Chienwichai, Phornpimon Tipthara, Joel Tarning, et al.
Malaria Journal|August 7, 2009
Towards optimal design of anti-malarial pharmacokinetic studiesJulie A Simpson, Kris M Jamsen, Ric N Price, et al.
Elife|October 30, 2019
Modeling the dynamics of <i>Plasmodium falciparum</i> gametocytes in humans during malaria infectionPengxing Cao, Katharine A Collins, Sophie Zaloumis, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar BorderFrank Kloprogge, Rose McGready, Warunee Hanpithakpong, et al.
Plos Neglected Tropical Diseases|March 30, 2022
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosingAlex P Salam, Alexandre Duvignaud, Marie Jaspard, et al.
Pageof 25

Showing results (61-70 of 248) with videos related to

Sort By:
Pageof 25
British Journal of Clinical Pharmacology|March 29, 2012
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometricsJ G Coen van Hasselt, Marilee A Andrew, Mary F Hebert, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2013
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in UgandaJoel Tarning, Frank Kloprogge, Mehul Dhorda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2018
Effect of Antiretroviral Therapy on Plasma Concentrations of Chloroquine and Desethyl-chloroquineMatthew M Ippolito, Jeffrey M Jacobson, Michael M Lederman, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN)Chris Lourens, Niklas Lindegardh, Karen I Barnes, et al.
Plos One|November 13, 2025
Mass spectrometry-based metabolomics uncovers distinct metabolic signatures and potential therapeutic targets in Plasmodium knowlesiNaphatsamon Uthailak, Sadudee Chotirat, Ammarind Anatjitsupha, et al.
Current Research in Parasitology & Vector-Borne Diseases|June 22, 2026
Shared urinary metabolomic signatures as potential biomarkers for early intestinal <i>Schistosoma</i> infection across multiple speciesPeerut Chienwichai, Phornpimon Tipthara, Joel Tarning, et al.
Malaria Journal|August 7, 2009
Towards optimal design of anti-malarial pharmacokinetic studiesJulie A Simpson, Kris M Jamsen, Ric N Price, et al.
Elife|October 30, 2019
Modeling the dynamics of <i>Plasmodium falciparum</i> gametocytes in humans during malaria infectionPengxing Cao, Katharine A Collins, Sophie Zaloumis, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar BorderFrank Kloprogge, Rose McGready, Warunee Hanpithakpong, et al.
Plos Neglected Tropical Diseases|March 30, 2022
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosingAlex P Salam, Alexandre Duvignaud, Marie Jaspard, et al.
Pageof 25